AARP “Rx Watchdog” Tracking Price Increases Ahead of Medicare Benefit
Executive Summary
An upcoming AARP "Rx Watchdog" study will analyze price increases enacted by manufacturers in the first quarter of 2004 heading into the launch of the Medicare drug discount card program
You may also be interested in...
Price Increases For Branded Drugs Slower Since Medicare Drug Card – AARP
The prices pharmaceutical manufacturers charge wholesalers for brand name drugs have been increasing at a slower rate since the Medicare drug discount card became available, AARP concludes in an "Rx Watchdog Report" released April 12
Price Increases For Branded Drugs Slower Since Medicare Drug Card – AARP
The prices pharmaceutical manufacturers charge wholesalers for brand name drugs have been increasing at a slower rate since the Medicare drug discount card became available, AARP concludes in an "Rx Watchdog Report" released April 12
PhRMA Studies Contest AARP Drug Price “Watchdog Report”
Prescription drug prices rose only 0.9% in the first quarter of 2004, not 3.4% as AARP claims, a study of Bureau of Labor Statistics data commissioned by the Pharmaceutical Research & Manufacturers of America says